ESPERION THERAPEUTICS Executives Sell Over 75% of Holdings in Routine Tax‑Settled RSU Disposals—No Red Flags Amid Upcoming Merger Flash.
Insider sales of ESPERION THERAPEUTICS shares reveal routine tax‑settlement moves, not confidence loss, as executives manage RSU payouts ahead of a potential merger.
3 minutes to read
